• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. REFOBACIN PLUS BONE CEMENT 40; ORTHOPAEDIC CEMENT, MEDICATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. REFOBACIN PLUS BONE CEMENT 40; ORTHOPAEDIC CEMENT, MEDICATED Back to Search Results
Catalog Number 3020830401
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Unspecified Infection (1930)
Event Date 10/15/2021
Event Type  Injury  
Manufacturer Narrative
This is a combination product (b)(4).Report source, foreign and health professional - event occurred in (b)(6).List of associated products : item 0059620421 _ articular surface with insert and locking screw use with lps/lps-flex 51 or 52 suffix femoralssize gh 17 mm height _ batch : 62920054; item 4020830401_ refobacin plus bone cement _batch ag10dl0103.The device manufacturing quality record indicate that the released product met all requirements to perform as intended.The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It was reported that: a patient underwent a knee arthroplasty on (b)(6) 11, 2017.Patient was revised due to infection on (b)(6) 2021.Patient involvement- revision surgery.
 
Event Description
It was reported that a patient underwent a knee arthroplasty.Patient was revised due to infection.No further adverse event was reported.
 
Manufacturer Narrative
This is a combination product: (b)(4).This follow-up is to relay additional information.No contributing conditions have been reported.The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It was reported that: a patient underwent a knee arthroplasty on (b)(6) 2017.Patient was revised due to infection on (b)(6) 2021.
 
Manufacturer Narrative
(b)(4).This follow-up is to relay additional information.X-rays shows the prosthesis implanted in the knee and review assessed that implant placement was well performed.So the most probable cause of a revision could not be related to implant placement, but indeed to infection.1 complaint on medical: revision was recorded on the batch since ever, and 1 complaint on medical: revision was recorded on the reference from (b)(6) 2018 to (b)(6) 2022.2 complaints on medical: infection was recorded on the batch since ever, and 3 complaints on medical: revision were recorded on the reference from (b)(6), 2018 to (b)(6), 2022.According to available data, root cause of the event was unable to be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN PLUS BONE CEMENT 40
Type of Device
ORTHOPAEDIC CEMENT, MEDICATED
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key12777639
MDR Text Key280508495
Report Number3006946279-2021-00195
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
Reporter Country CodeAS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/09/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2019
Device Catalogue Number3020830401
Device Lot NumberA610DL0103
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received12/05/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/15/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SEE H10 FOR ASSOCIATEDPRODUCTS.
Patient Outcome(s) Hospitalization;
Patient Age83 YR
Patient SexMale
-
-